论文部分内容阅读
ＨＩＶ1感染病人应用含蛋白酶抑制剂在内的积极抗逆病毒疗法(ＨＡＡＲＴ)治疗可获益,其机制归因于该疗法对ＨＩＶ1病毒复制的抑制,不过瑞士的一项研究发现约有49%用ＨＡＡＲＴ治疗的病人并未达到病毒抑制,有些人仍有病毒血症。作者随访了101例1997年2月以前开始应用ＨＡＡＲＴ
Active antiretroviral therapy (HAART) with protease inhibitors can benefit HIV-1 infected patients due to the mechanism of inhibition of HIV 1 virus replication by this therapy, although a Swiss study found that about 49% HAART-treated patients did not achieve viral suppression, and some still had viremia. The authors followed 101 patients who started using HAART before February 1997